Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-15 pm EDT 5-day change 1st Jan Change
397.4 USD +0.20% Intraday chart for Vertex Pharmaceuticals Incorporated -1.70% -2.34%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
North American Morning Briefing : Big Banks Kick -2- DJ
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech MT
Health Care Slips on Risk Bias -- Health Care Roundup DJ
Wall Street rebounds on softer inflation data, eyes on earnings RE
Global markets live: Airbus, UBS, KKR, Meta Platforms, Tesla... Our Logo
Sector Update: Health Care Stocks Steady Pre-Bell Thursday MT
Western Drugmakers Seeking Alternative Suppliers as US Looks to Restrict Chinese Biotech MT
Will there be any Fed rate cuts this year? Our Logo
Nasdaq set for higher open as fresh inflation data allays rate jitters RE
Wholesale Prices Rise Less Than Expected in March as US Equity Futures Waver Pre-Bell MT
Sector Update: Health Care MT
HC Wainwright Raises Vertex Pharmaceuticals' Price Target to $462 From $457, Maintains Buy Rating MT
Wedbush Downgrades Alpine Immune Sciences to Neutral From Outperform, Raises Price Target to $65 From $47, Expects Vertex Deal to Close MT
Top Premarket Gainers MT
Vertex Pharmaceuticals' $4.9 Billion Deal for Alpine Shows Lead-Candidate's Potential, Analysts Say MT
Evercore ISI Upgrades Vertex Pharmaceuticals to Outperform From In Line MT
News Highlights : Top Company News of the Day - Thursday at 7 AM ET DJ
North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ
RBC Downgrades Alpine Immune Sciences to Sector Perform From Outperform, Removes Speculative Risk, Lifts Price Target to $65 From $41 Amid Vertex Deal MT
Futures slip as rate-cut hopes ebb RE
European Midday Briefing : ECB Expected to Hold Rates, Lagarde Message Key DJ
News Highlights : Top Company News of the Day - Thursday at 5 AM ET DJ
News Highlights : Top Company News of the Day - Thursday at 3 AM ET DJ
News Highlights : Top Company News of the Day - Thursday at 1 AM ET DJ
News Highlights : Top Company News of the Day - Wednesday at 11 PM ET DJ
Chart Vertex Pharmaceuticals Incorporated
More charts
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
397.4 USD
Average target price
461.3 USD
Spread / Average Target
+16.08%
Consensus
  1. Stock Market
  2. Equities
  3. VRTX Stock
  4. News Vertex Pharmaceuticals Incorporated
  5. Vertex Pharmaceuticals Insider Sold Shares Worth $1,519,637, According to a Recent SEC Filing